In contrast to the research conducted with pancreatic lipase or cholesterol esterase, there has been a paucity of studies determining the potential anti-obesity properties of bioactive compounds in combination with orlistat in other biological models or clinical trials. Here, PNLIP is linked to obesity due to melanocortin 4 receptor deficiency.